Manuscripts
Deep learning-based codon optimization with large-scale synonymous variant datasets enables generalized tunable protein expression
Unlocking de novo antibody design with generative artificial intelligence
Posters
Development of ABS-101: A potential best-in-class anti-TL1A antibody for the treatment of IBD
Science Blogs
Anyone can generate thousands of new AI drug candidates. What matters is one great lead.
Programming E. coli to outsmart disease
